<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02993510</url>
  </required_header>
  <id_info>
    <org_study_id>10830-003</org_study_id>
    <nct_id>NCT02993510</nct_id>
  </id_info>
  <brief_title>A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.</brief_title>
  <official_title>Randomised Multi-Center Study: Microfracturing With Chondro-Gide® for the Treatment of Isolated Cartilage Defects in the Knee Project-Nr.: 10830-003</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Geistlich Pharma AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Geistlich Pharma AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of using Chondro-Gide®
      collagen membrane either sutured or glued compared to microfracture alone in the treatment of
      symptomatic cartilage defects of the knee.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Prospective, randomized, active treatment-controlled, open-label multicenter study (up
           to 40 sites in the US and EU).

        -  All subjects that meet preoperative screening eligibility criteria will be randomized to
           treatment with Chondro-Gide® either sutured or glued or Microfracture alone.

        -  Eligible and consenting subjects are randomized in a 1:1:1 ratio using centralized
           randomization list to receive one of the following treatments: Group I: Microfracture
           alone; Group II: Microfracture covered with a Chondro-Gide® membrane glued with fibrin
           glue (AMIC glued); Group III: Microfracture covered with a Chondro-Gide® membrane
           sutured (AMIC sutured)

        -  All subjects will be assessed at intervals post-procedure (6 weeks, 3 months, and 1,2
           and 5 years).

        -  Subjects will be required to follow a strict pre-specified post-surgery rehabilitation
           protocol specific to the defect location.

        -  Measures to assess effectiveness and safety will be conducted at all follow-ups.

        -  Safety will be assessed by the collection of adverse events at all timepoints.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2003</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histological evaluation of structural repair of evaluable biopsies harvested from the core of the index lesion during arthroscopy at 2 years</measure>
    <time_frame>2 years post-surgery</time_frame>
    <description>The macroscopically assessed integration, surface properties and extent of filling of the defect and the microscopically assessed using the International Cartilage Repair Society (ICRS) score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MRI (magnetic resonance imaging) assessment of structural repair parameters.</measure>
    <time_frame>6 months and 1,2 and 5 years post-surgery</time_frame>
    <description>Structural repair is assessed with magnetic resonance imaging (MRI, 1.5T) by an independent and blinded radiologist, with a focus on the extent, signal intensity and surface of the defect filling, integration to adjacent cartilage, and bone marrow lesion (BML).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in the patient's evaluation of overall knee condition using the Modified Cincinnati Knee Rating System.</measure>
    <time_frame>6 months and 1,2 and 5 years post-surgery</time_frame>
    <description>The Change from Baseline will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in the patient's evaluation of pain using the Visual Analog Scale (VAS).</measure>
    <time_frame>6 months and 1,2 and 5 years post-surgery</time_frame>
    <description>The Change from Baseline will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in the patient's evaluation of overall knee condition using the International Cartilage Repair Society (ICRS) &quot;Cartilage Injury Evaluation Package&quot;.</measure>
    <time_frame>6 months and 1,2 and 5 years post-surgery</time_frame>
    <description>The Change from Baseline will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events (AE) Review</measure>
    <time_frame>5 years post-surgery</time_frame>
    <description>The incidence, timing, severity, and relationship to treatment of all Adverse Events (AE), will be collected for all participants.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Cartilage Injury</condition>
  <condition>Osteochondritis Dissecans</condition>
  <arm_group>
    <arm_group_label>microfracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Microfracture is an arthroscopic surgical technique involving placement of microfracture penetrations within the cartilage defect to provide stem cells and growth factors from the bone marrow to aid cartilage repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfracture with Chondro-Gide sutured</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microfracture covered with a collagen membrane (Chondro-Gide®) using atraumatic sutures in a one-step mini-arthrotomy procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfracture with Chondro-Gide glued</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microfracture covered with a collagen membrane (Chondro-Gide®) using fibrin glue in a one-step mini-arthrotomy procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microfracture</intervention_name>
    <description>Microfracture is a well-established arthroscopic surgical technique for cartilage repair which involves several systematic steps, including debridement to a stable cartilage margin, careful removal of the calcified cartilage layer, and homogeneous placement of microfracture penetrations within the cartilage defect, with resultant complete defect fill by a well-anchored clot</description>
    <arm_group_label>microfracture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chondro-Gide sutured</intervention_name>
    <description>Implantation of Chondro-Gide membrane using atraumatic sutures following microfracture via mini-arthrotomy</description>
    <arm_group_label>Microfracture with Chondro-Gide sutured</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chondro-Gide glued</intervention_name>
    <description>Implantation of Chondro-Gide membrane using Fibrin glue following microfracture via mini-arthrotomy</description>
    <arm_group_label>Microfracture with Chondro-Gide glued</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female between 18 and 50

          -  One or two cartilage defects Grade III or IV according to Outerbridge classification

          -  Defect size between 2 and 10 cm2 (inclusive)

          -  Intact normal surrounding cartilage to suture the Chondro-Gide® membrane

          -  Informed consent

          -  Patient willing to fulfill a strict postoperative physiotherapy scheme

        Exclusion Criteria:

          -  More than 2 defects

          -  Defects on both knees

          -  X-ray signs of osteoarthritis

          -  Bone lesion &gt; 0.7 cm in the defect

          -  Knee instability, varus or valgus deformation, status after complete meniscus
             resection, status after mosaicplasty, patella dysplasia

          -  Rheumatoid, infectious disease

          -  Skin lesion on the operated knee

          -  Treatment with cartilage building medication

          -  Drug and alcohol abuse

          -  Chronic heart disease, endocrine or metabolic disease, Haemophilia A/B

          -  Pregnancy or lactation

          -  Collagen allergy

          -  Participation in other Trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven Anders, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Regensburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Regensburg</name>
      <address>
        <city>Bad Abbach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen</name>
      <address>
        <city>Giessen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedikum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallklinik Hannover</name>
      <address>
        <city>Hanover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Schleswig-Holstein</name>
      <address>
        <city>Lubeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sportklinik Ravensburg</name>
      <address>
        <city>Ravensburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Anders S, Volz M, Frick H, Gellissen J. A Randomized, Controlled Trial Comparing Autologous Matrix-Induced Chondrogenesis (AMIC®) to Microfracture: Analysis of 1- and 2-Year Follow-Up Data of 2 Centers. Open Orthop J. 2013 May 3;7:133-43. doi: 10.2174/1874325001307010133. Print 2013.</citation>
    <PMID>23730377</PMID>
  </results_reference>
  <results_reference>
    <citation>Volz M, Schaumburger J, Frick H, Grifka J, Anders S. A randomized controlled trial demonstrating sustained benefit of Autologous Matrix-Induced Chondrogenesis over microfracture at five years. Int Orthop. 2017 Apr;41(4):797-804. doi: 10.1007/s00264-016-3391-0. Epub 2017 Jan 20.</citation>
    <PMID>28108777</PMID>
  </results_reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2016</study_first_posted>
  <last_update_submitted>February 20, 2017</last_update_submitted>
  <last_update_submitted_qc>February 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microfracture</keyword>
  <keyword>enhanced marrow stimulation</keyword>
  <keyword>articular cartilage</keyword>
  <keyword>Autologous Matrix-Induced Chondrogenesis</keyword>
  <keyword>Chondro-Gide®</keyword>
  <keyword>knee surgery</keyword>
  <keyword>AMIC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Stress</mesh_term>
    <mesh_term>Osteochondritis</mesh_term>
    <mesh_term>Osteochondritis Dissecans</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

